Kinetic, equilibrium, and thermodynamic aspects of phenol adsorption onto acrylonitrile-divinylbenzene copolymer

Autor: Neziri, Elsada, Duranoğlu, Dilek

Publikováno v: In Science of the Total Environment 1 December 2024 954

A registry study of relapsed or refractory multiple myeloma pre‐exposed to three or more prior therapies including a proteasome inhibitor, an immunomodulatory agent and CD38‐targeted monoclonal antibody therapy in England

Autor: Ahmed Elsada, Amy Zalin‐Miller, Craig Knott, Leonidas Caravotas

Publikováno v: eJHaem, Vol 2, Iss 3, Pp 493-497 (2021)

Abstract Some patients with multiple myeloma are receiving treatment in clinical practice in England after prior exposure to a proteasome inhibitor, an immunomodulatory agent, and an anti‐CD38 monoclonal antibody. We investigated the characteristic

Externí odkaz: https://doaj.org/article/8c7a3d7ead32426fa7e402ef0d2fb940

PENGARUH SPIRITUALITAS DAN KECERDASAN EMOSIONAL TERHADAP KESEJAHTERAAN KARYAWAN DENGAN PERILAKU MENYIMPANG DITEMPAT KERJA SEBAGAI PEMODERASI

Autor: Christine Elsada

Publikováno v: AKSIOMA : Jurnal Manajemen. 1:108-122

This study aims to determine the effect of spirituality and emotional intelligence on the employees well-being with deviant behavior in the workplace as a moderator. The population in this study were nurses at Siloam Kupang Hospital, Siloam Labuan Ba

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9bcb4aa3a34be7854b8f4b4861290936
https://doi.org/10.30822/aksioma.v1i2.1808

Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma

Autor: Philippe Moreau, Niels W. C. J. van de Donk, Michel Delforge, Hermann Einsele, Valerio De Stefano, Aurore Perrot, Britta Besemer, Charlotte Pawlyn, Lionel Karlin, Salomon Manier, Xavier Leleu, Katja Weisel, Francesca Ghilotti, Joris Diels, Ahmed Elsada, Raul Morano, Vadim Strulev, Lixia Pei, Rachel Kobos, Jennifer Smit, Mary Slavcev, Maria-Victoria Mateos

Publikováno v: Advances in therapy, 40(5), 2412-2425. Health Communications Inc.
Moreau, P, van de Donk, N W C J, Delforge, M, Einsele, H, de Stefano, V, Perrot, A, Besemer, B, Pawlyn, C, Karlin, L, Manier, S, Leleu, X, Weisel, K, Ghilotti, F, Diels, J, Elsada, A, Morano, R, Strulev, V, Pei, L, Kobos, R, Smit, J, Slavcev, M & Mateos, M-V 2023, ' Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma ', Advances in therapy, vol. 40, no. 5, pp. 2412-2425 . https://doi.org/10.1007/s12325-023-02480-7

Introduction: Patients with triple-class-exposed relapsed/refractory multiple myeloma (TCE-RRMM) have a poor prognosis and limited treatment options. Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, was studied in patients with TC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::746daa9720cdcf7afd4c135f602304b1
https://research.vumc.nl/en/publications/5b5a88cd-71df-484d-8110-0cb6098e1ef9

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.